T F Blaschke

Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans.

C C Peck, L J Lesko, M Rowland, 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Gentamicin pharmacokinetics in neonates undergoing extracorporal membrane oxygenation

T F Blaschke, T. Blaschke, C. Prober, 1990, The Pediatric infectious disease journal.

Defective bromosulfophthalein clearance in patients with constitutional hepatic dysfunction (Gilbert's syndrome).

P D Berk, T F Blaschke, T. Blaschke, 1972, Gastroenterology.

Potential of population pharmacokinetics to reduce the frequency of blood sampling required for estimating kinetic parameters in neonates.

T F Blaschke, T. Blaschke, C. Prober, 1992, Developmental pharmacology and therapeutics.

Medication compliance as a feature in drug development.

T F Blaschke, T. Blaschke, H. Kastrissios, 1997, Annual review of pharmacology and toxicology.

Nicotine impairs endothelium‐dependent dilatation in human veins in vivo

T F Blaschke, N. Benowitz, T. Blaschke, 2000, Clinical pharmacology and therapeutics.

Patient compliance and drug failure in protease inhibitor monotherapy.

T F Blaschke, T. Merigan, J. Schapiro, 1996, JAMA.

A Markov mixed effect regression model for drug compliance.

L B Sheiner, T F Blaschke, T. Blaschke, 1998, Statistics in medicine.

Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy

L B Sheiner, T F Blaschke, D Verotta, 1997, Antimicrobial agents and chemotherapy.